Patents by Inventor Robert Eugene BOYD

Robert Eugene BOYD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11912693
    Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of S1P1 receptor and methods of using the same.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: February 27, 2024
    Assignee: TREVENA, INC.
    Inventors: Philip Michael Pitis, Robert Eugene Boyd, Tamara Ann Miskowski Daubert, Michael John Hawkins, Guodong Liu, Aimee Crombie Speerschneider
  • Publication number: 20230234946
    Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of S1P1 receptor and methods of using the same.
    Type: Application
    Filed: April 5, 2023
    Publication date: July 27, 2023
    Inventors: Philip Michael Pitis, Robert Eugene Boyd, Tamara Ann Miskowski Daubert, Michael John Hawkins, Guodong Liu, Aimee Crombie Speerschneider
  • Publication number: 20210188826
    Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of S1P1 receptor and methods of using the same.
    Type: Application
    Filed: June 12, 2018
    Publication date: June 24, 2021
    Inventors: Philip Michael PITIS, Robert Eugene BOYD, Tamara Ann Miskowski DAUBERT, Michael John HAWKINS, Guodong LIU, Aimee Crombie SPEERSCHNEIDER